[1]Vege SS,Gardner TB,Chari ST,et al.Low mortality and high morbidity in severe acute pancreatitis without organ failure:a case for revising the Atlanta classification to include “moderately severe acute pancreatitis”[J].The American Journal of Gastroenterology,2009,104(3):710-715.
[2]中华医学会消化病学分会胰腺疾病学组,《中华胰腺病杂志》编辑委员会,《中华消化杂志》编辑委员会.中国急性胰腺炎诊治指南(2019,沈阳)[J].中华胰腺病杂志,2019,19(5):35-38.
[3]孔婧,王晓素,周秉舵,等.中西医结合疗法治疗急性胰腺炎临床观察[J].上海中医药杂志,2015,49(12):39-41.
[4]周秉舵,方盛泉,朱生樑,等.清下解胰方鼻饲加灌肠联合西药治疗重症急性胰腺炎临床观察[J].上海中医药杂志,2015,49(4):44-46.
[5]周秉舵,徐亭亭,孔婧,等.清下解胰方改善重症胰腺炎患者肠屏障功能的临床研究[J].上海中医药大学学报,2015,29(1):33-36.
[6]王兴鹏,李兆申,袁耀宗,等.中国急性胰腺炎诊治指南(2013,上海)[J].中国实用内科杂志,2013,33(7):530-535.
[7]Glasbrenner B,Adler G.Pathophysiology of acute pancreatitis[J].Hepatogastroenterology,1993,40(6):517-21.
[8]Hajnády Z,NagyPénzes M,Demény MA,et al.OGG1 inhibition reduces acinar cell injury in a mouse model of acute pancreatitis[J].Biomedicines,2022,10(10):2543.
[9]Pandol SJ,Gottlieb RA.Calcium,mitochondria and the initiation of acute pancreatitis[J].Pancreatology,2022,22(7):838-845.
[10]陈婧华,陈垦,王晖.急性胰腺炎发病机制研究进展[J].世界华人消化杂志,2009,17(24):2478-2483.
[11]侯俊明,王建华.攻下法在重症急性胰腺炎治疗中的临床作用[J].现代中医药,2010,30(6):29-30.
[12]Singh N,Sonika U,Moka P,et al.Association of endotoxaemia & gut permeability with complications of acute pancreatitis:Secondary analysis of data[J].Indian J Med Res,2019,149(6):763-770.
[13]NormanJG,Fink GW,Denham W,et al.Tissuespecific cytokine production during experimental acute pancreatitis.A probable mechanism for distant organ dysfunction[J].Digestive Diseases and Sciences,1997,42(8):1783-1788.
[14]孔婧,王晓素,姜清宇,等.清下化瘀方对急性胰腺炎胃肠道及免疫功能的保护作用[J].中国中西医结合消化杂志,2014,22(5):245-248,252.
[15]Riedel S,Melendez JH,An AT,et al.Procalcitonin as a marker for the detection of bacteremia and sepsis in the emergency department[J].American Journal of Clinical Pathology,2011,135(2):182-189.
[16]GurdaDuda A,Ku s'nierzCabala B,Nowak W,et al.Assessment of the prognostic value of certain acutephase proteins and procalcitonin in the prognosis of acute pancreatitis[J].Pancreas,2008,37(4):449-453.
[17]Bulbuller N.Dogru O,Ayten R,et al.Procalcitonin is a predictive marker for severe acute pancreatitis[J].Ulus Travma Acil Cerrahi Derg,2006,12(2):115-120.
[18]Kolber W,Dumnicka P,Maraj M,et al.Does the automatic measurement of interleukin 6 allow for prediction of complications during the first 48 h of acute pancreatitis?[J].International Journal of Molecular Sciences,2018,19(6):1820.
[19]Staubli SM,Oertli D,Nebiker CA.Laboratory markers predicting severity of acute pancreatitis[J].Critical Reviews in Clinical Laboratory Sciences,2015,52(6):273-283.
[20]Hirano T.IL6 ininflammation,autoimmunity and cancer[J].International Immunology,2021,33(3):127-148.
[21]Vasseur P,Devaure I,Sellier J,et al.High plasma levels of the proinflammatory cytokine IL-22 and the antiinflammatory cytokines IL-10 and IL1ra in acute pancreatitis[J].Pancreatology,2014,14(6):465-469.
[22]Tran TH,Rastogi R,Shelke J,et al.Modulation of macrophage functional polarity towards antiinflammatory phenotype with plasmid DNA delivery in CD44 targeting hyaluronic acid nanoparticles[J].Scientific Reports,2015,5:16632.
[23]Yang XM,Yao LB,Fu XH,et al.Experimental acute pancreatitis models:history,current status,and role in translational research[J].Frontiers in Physiology,2020,11:614591.
[24]Zhang FH,Sun YH,Fan KL,et al.Protective effects of heme oxygenase-1 against severe acute pancreatitis via inhibition of tumor necrosis factor-α and augmentation of interleukin-10[J].BMC Gastroenterology,2017,17(1):100.
基金项目:国家自然科学基金委员会青年项目(82004264);上海市申康医院发展中心中西医临床协作试点建设项目(ZY2018-2020-FWTX-1004)